Univest
Univest
  • Markets

Sharda Cropchem vs Dhanuka Agritech 2027: Global Generics vs Indian Farm Brands, and a P/E Under 10 for One

  • November 20, 2026
  • Posted by: Ankit Jaiswal
  • Category: Market
No Comments
Sharda Cropchem vs Dhanuka Agritech 2027: Global Generics vs Indian Farm Brands, and a P/E Under 10 for One
Sharda Cropchem vs Dhanuka Agritech at a glance Sharda Cropchem Dhanuka Agritech
Share price (19 Nov 2026) Rs 671.05 Rs 918.00
Market cap Rs 6,059 crore Rs 4,093 crore
P/E ratio 9.42 14.45
Q2 FY27 net profit Rs 91.7 crore Rs 109.2 crore

Quick Answer

Sharda Cropchem vs Dhanuka Agritech compares an export-focused agrochemical company with a domestic, farmer-focused brand. In Q2 FY27, Sharda’s revenue rose 14.4% to Rs 1,096 crore and net profit 23.4% to Rs 92 crore. Dhanuka’s revenue rose 10.3% to Rs 667 crore and net profit 16.2% to Rs 109 crore. Sharda trades at a P/E of 9.42 with a 19.80% ROE and a 2.23% dividend yield, against 14.45, 16.21% and 0.22% for Dhanuka.

Sharda Cropchem vs Dhanuka Agritech in 2027 puts two profitable agrochemical companies side by side at low valuations: Sharda trades at 9.42 times earnings and Dhanuka at 14.45 times, both well below the sector, and both grew profit in the September quarter. Yet Sharda’s share price is about 48% below its 52-week high. The Sharda Cropchem vs Dhanuka Agritech agrochemicals comparison explains why.

Sharda Cropchem is valued at about Rs 6,059 crore and Dhanuka Agritech at about Rs 4,093 crore, and investors often measure small agri stocks like these against the Nifty 500. This guide compares their business models, valuation, Q2 FY27 results, 2027 drivers, risks and shareholding.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Sharda Cropchem vs Dhanuka Agritech: Company Overview
    • What Sharda Cropchem Does
    • What Dhanuka Agritech Does
  • How Sharda Cropchem and Dhanuka Agritech Make Money
  • Sharda Cropchem vs Dhanuka Agritech Valuation
  • Sharda Cropchem vs Dhanuka Agritech Q2 FY27 Results
  • Sharda Cropchem vs Dhanuka Agritech Agrochemicals Outlook for 2027
    • Sharda: global recovery
    • Dhanuka: domestic brands and new molecules
  • Risks in Sharda Cropchem vs Dhanuka Agritech
    • Risks for Sharda Cropchem
    • Risks for Dhanuka Agritech
  • Sharda Cropchem vs Dhanuka Agritech Shareholding
  • Which Investor Does Each Agrochemical Stock Suit?
    • Sharda Cropchem suits value and dividend investors
    • Dhanuka Agritech suits investors who want Indian farm exposure
  • Final View on Sharda Cropchem vs Dhanuka Agritech
  • FAQs on Sharda Cropchem vs Dhanuka Agritech
    • What is the main difference between Sharda Cropchem and Dhanuka Agritech?
    • How did Sharda Cropchem perform in Q2 FY27?
    • How did Dhanuka Agritech perform in Q2 FY27?
    • Which agrochemical stock has the lower P/E?
    • Which company pays a higher dividend yield?
    • How far are both stocks from their 52-week highs?
    • Is Sharda Cropchem vs Dhanuka Agritech a buy or sell decision?

Sharda Cropchem vs Dhanuka Agritech: Company Overview

What Sharda Cropchem Does

Sharda Cropchem is a Mumbai-based agrochemical company that registers and sells off-patent crop protection products in Europe, Latin America, North America and other markets. It runs an asset-light model, sourcing products from manufacturers rather than making them. Promoters hold 74.82%.

What Dhanuka Agritech Does

Dhanuka Agritech is a Gurugram-based company that sells branded insecticides, herbicides and fungicides to Indian farmers through a large dealer network. It often launches new molecules in partnership with global agrochemical companies. Promoters hold 69.81%.

How Sharda Cropchem and Dhanuka Agritech Make Money

Sharda’s value lies in its large portfolio of product registrations in regulated overseas markets, which take years to obtain. It earns by selling generic products in those markets, so its results depend on global agrochemical prices, sourcing costs and currencies.

Dhanuka earns almost all its revenue in India, where demand depends on the monsoon, crop prices and pest outbreaks. Its June and September quarters, covering the kharif season, are usually its strongest.

Sharda Cropchem vs Dhanuka Agritech Valuation

These figures use the 19 November 2026 close and trailing twelve month ratios. Industry P/E is shown as reported for each company’s category.

Sharda Cropchem vs Dhanuka Agritech metric Sharda Cropchem Dhanuka Agritech
Share price (CMP) Rs 671.05 Rs 918.00
52-week high Rs 1,297.00 Rs 1,265.00
52-week low Rs 622.50 Rs 820.00
Distance from 52-week high -48.3% -27.4%
Market capitalisation Rs 6,059 crore Rs 4,093 crore
P/E ratio (TTM) 9.42 14.45
Industry P/E 22.36 25.38
P/B ratio 1.86 2.34
Return on equity (ROE) 19.80% 16.21%
Debt to equity 0.01 0.02
Dividend yield 2.23% 0.22%

The Sharda Cropchem vs Dhanuka Agritech table shows Sharda trading at a P/E of 9.42 and 1.86 times book, against 14.45 and 2.34 for Dhanuka. Both trade well below their industry P/E levels.

Sharda has the higher return on equity at 19.80% against 16.21%, and a far higher dividend yield of 2.23% against 0.22%. Both companies are almost debt-free.

Sharda at Rs 671.05 is about 48.3% below its 52-week high of Rs 1,297 and about 8% above its low. Dhanuka at Rs 918 is about 27.4% below its high of Rs 1,265.

Sharda Cropchem vs Dhanuka Agritech Q2 FY27 Results

Figures below are consolidated revenue and net profit for the quarter ended 30 September 2026.

Sharda Cropchem vs Dhanuka Agritech Q2 FY27 (Sep 2026 quarter) Sharda Cropchem Dhanuka Agritech
Revenue Q2 FY27 Rs 1,096 crore Rs 666.7 crore
Revenue Q2 FY26 Rs 958.5 crore Rs 604.6 crore
Revenue change YoY +14.4% +10.3%
Net profit Q2 FY27 Rs 91.7 crore Rs 109.2 crore
Net profit Q2 FY26 Rs 74.4 crore Rs 94.0 crore
Net profit change YoY +23.4% +16.2%
Net profit Q1 FY27 Rs 88.0 crore Rs 36.3 crore

In the Q2 FY27 results, Sharda’s revenue rose 14.4% to Rs 1,096 crore and net profit rose 23.4% to Rs 91.7 crore. Its operating margin improved to 19.9% from 17.5%.

Dhanuka’s revenue rose 10.3% to Rs 667 crore and net profit rose 16.2% to Rs 109.2 crore, up sharply from Rs 36.3 crore in the June quarter. Its operating margin was 24.7%.

Both companies grew profit in the quarter. Dhanuka earned more profit on lower revenue because of its higher-margin branded model.

Sharda Cropchem vs Dhanuka Agritech Agrochemicals Outlook for 2027

Sharda: global recovery

Sharda’s FY26 revenue rose 23.5% to Rs 5,410 crore and net profit more than doubled to Rs 681 crore, as global agrochemical demand recovered from a downturn. Its share price has nevertheless fallen sharply, which keeps its P/E below 10.

Its 2027 results depend on global pricing, product registrations and currency movements.

Dhanuka: domestic brands and new molecules

Dhanuka’s growth depends on the monsoon, farm incomes and new product launches with global partners. A strong kharif season supported its September quarter profit.

In the Sharda Cropchem vs Dhanuka Agritech comparison, Dhanuka offers steadier domestic exposure, while Sharda offers global exposure at a lower valuation.

Compare agri stocks on the Univest Screener

Risks in Sharda Cropchem vs Dhanuka Agritech

Risks for Sharda Cropchem

Sharda’s main risks are global agrochemical price swings, dependence on imported products, currency moves and regulatory changes in Europe. Foreign institutions cut their stake from 5.26% to 3.27%.

Risks for Dhanuka Agritech

In the Sharda Cropchem vs Dhanuka Agritech risk check, Dhanuka’s main risks are monsoon dependence, competition from generic products in India and credit risk from dealers. Its dividend yield is low at 0.22%.

Sharda Cropchem vs Dhanuka Agritech Shareholding

Sharda Cropchem vs Dhanuka Agritech shareholding (Sep ’26, change vs Sep ’25) Sharda Cropchem Dhanuka Agritech
Promoters 74.82% (+0.00 pts) 69.81% (+0.10 pts)
Foreign institutions (FII) 3.27% (-1.99 pts) 1.59% (-0.71 pts)
Domestic institutions (DII) 9.22% (-0.04 pts) 19.28% (+1.21 pts)
Public and others 12.69% (+2.04 pts) 9.32% (-0.59 pts)

Sharda promoters hold 74.82%, unchanged. Domestic institutions hold 9.22% and the public stake rose to 12.69%.

Dhanuka promoters hold 69.81%. Domestic institutions raised their stake from 18.07% to 19.28%. In Sharda Cropchem vs Dhanuka Agritech, both companies have high promoter holdings.

Download the Univest iOS App or Univest Android App to track Sharda Cropchem and Dhanuka Agritech live and follow agri research.

Which Investor Does Each Agrochemical Stock Suit?

Sharda Cropchem suits value and dividend investors

Within Sharda Cropchem vs Dhanuka Agritech, Sharda fits investors who want a low P/E, a high ROE and a dividend yield above 2%, with global exposure. They need to accept global price swings and a weak share price trend.

Dhanuka Agritech suits investors who want Indian farm exposure

Dhanuka fits investors who want a domestic agrochemical brand with high margins and low debt. They need to accept monsoon-related swings.

Final View on Sharda Cropchem vs Dhanuka Agritech

Sharda Cropchem vs Dhanuka Agritech pairs an export-led generic agrochemical company with a domestic brand. Sharda trades at 9.42 times earnings with a 19.80% ROE and a 2.23% yield. Dhanuka grew Q2 FY27 profit 16.2% and trades at 14.45 times.

The Sharda Cropchem vs Dhanuka Agritech outlook for 2027 depends on global agrochemical prices for Sharda and the monsoon for Dhanuka.

Disclaimer: Data and figures in this article are drawn from publicly available information and company disclosures, and they may change after publication. Please verify all data independently before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on Sharda Cropchem vs Dhanuka Agritech

What is the main difference between Sharda Cropchem and Dhanuka Agritech?

Ans. Sharda Cropchem sells off-patent agrochemicals mainly in overseas markets such as Europe and Latin America. Dhanuka Agritech sells branded crop protection products to Indian farmers. Sharda depends on global prices and currencies. Dhanuka depends on the Indian monsoon and farm demand.

How did Sharda Cropchem perform in Q2 FY27?

Ans. Sharda's revenue rose 14.4% to Rs 1,096 crore and net profit rose 23.4% to Rs 91.7 crore in Q2 FY27. Its operating margin improved to 19.9% from 17.5%. Profit was higher than the June quarter's Rs 88 crore. FY26 profit had more than doubled to Rs 681 crore.

How did Dhanuka Agritech perform in Q2 FY27?

Ans. Dhanuka's revenue rose 10.3% to Rs 667 crore and net profit rose 16.2% to Rs 109.2 crore in Q2 FY27. Profit was up sharply from Rs 36.3 crore in the June quarter. Its operating margin was 24.7%. The kharif season supported results.

Which agrochemical stock has the lower P/E?

Ans. Sharda Cropchem trades at a P/E of 9.42, compared with 14.45 for Dhanuka Agritech. Both trade well below their industry averages. Sharda also has a higher ROE of 19.80%. Valuations change with prices and earnings.

Which company pays a higher dividend yield?

Ans. Sharda Cropchem has a dividend yield of 2.23%, compared with 0.22% for Dhanuka Agritech. Sharda's low share price lifts its yield. Both companies are almost debt-free. Yields change as share prices move.

How far are both stocks from their 52-week highs?

Ans. Sharda closed at Rs 671.05 on 19 November 2026, about 48.3% below its 52-week high of Rs 1,297. Dhanuka closed at Rs 918, about 27.4% below its high of Rs 1,265. Sharda's 52-week low is Rs 622.50 and Dhanuka's is Rs 820. Prices change daily.

Is Sharda Cropchem vs Dhanuka Agritech a buy or sell decision?

Ans. This Sharda Cropchem vs Dhanuka Agritech comparison is educational and does not give a buy or sell call. Sharda offers a low P/E and high dividend yield with global price risk, while Dhanuka offers domestic exposure with monsoon risk. Both are almost debt-free. Investors should consult a SEBI-registered adviser before acting.



2027 agrochemicals Dhanuka Agritech Sharda Cropchem Stock Comparison
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply